Cor Vasa 2019, 61(1):15-19 | DOI: 10.1016/j.crvasa.2018.06.003

Pulmonary embolism cohort in Pisek Hospital

Miroslav Kodým
Interní oddělení, Nemocnice Písek, Písek

We present retrospective unselected cohort of 204 consecutive patients treated for pulmonary embolism at Internal medicine department of Hospital Písek. We achieved low in-patient mortality (5.88%) even with a very conservative use of thrombolysis (8.82%). In total there were 39 patients with high risk PE (2009 Czech nomenclature as "massive"), 44 with intermediate-risk PE (2009 Czech nomenclature as "submassive"), 121 with low-risk PE (2009 Czech nomenclature as "small"). Data were collected before 2014 ESC guidelines and PEITHO study. CTA was performed in 81.86% of patients. It is an excellent diagnostic tool, but in urgent cases its use is often limited by patients' haemodynamic instability. In our case 16 patients with massive PE had no CTA, of which 12 underwent emergency echocardiography and doppler ultrasound of lower extremity veins. Four patients were diagnosed after unsuccessful CPR by bed-side ultrasound techniques.

Keywords: Cohort, Pulmonary embolism

Published: March 21, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kodým M. Pulmonary embolism cohort in Pisek Hospital. Cor Vasa. 2019;61(1):15-19. doi: 10.1016/j.crvasa.2018.06.003.
Download citation

References

  1. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004;117:19-25. Go to original source... Go to PubMed...
  2. Oger E. Incidence of venous thromboembolism in a community-based study in western France, Thromb Haemost 2000;83:657-660. Go to original source... Go to PubMed...
  3. Goldhaber SZ, Visani L, De Rosa M, for ICOPER. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-1389. Go to original source...
  4. Sweet III PH, Armstrong T, Chen J, et al. Fatal pulmonary embolism update: 10 years of autopsy experience at an academic medical center. JRSM Short Rep 2013;4(9):2042533313489824 Go to original source... Go to PubMed...
  5. Geibel A, Zehender M, Kasper W, et al. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Eur Resp J 2005;25:843-848. Go to original source... Go to PubMed...
  6. Laporte S, Mismetti P, Décousus H, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008;117:1711-1716. Go to original source... Go to PubMed...
  7. Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004;140:589-602. Go to original source...
  8. Lankeit M, Jiménez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified pulmonary embolism severity index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation 2011;124 :2716-2724. Go to original source... Go to PubMed...
  9. Kearon C, Ginsberg JS, Douketis J, et al. An evaluation of Ddimer in thediagnosis of pulmonary embolism: a randomized trial. Ann Intern Med 2006;144:812-821. Go to original source...
  10. Jiménez D, Uresandi F, Otero R, et al. Troponin-based risk stratification of patients with acute non-massive pulmonary embolism: systematic review and metaanalysis. Chest 2009;136:974-982. Go to original source... Go to PubMed...
  11. Vuilleumier N, Le Gal G, Verschuren F, et al. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study. J Thromb Haemost 2009;7:391-398. Go to original source... Go to PubMed...
  12. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713. Go to original source... Go to PubMed...
  13. Coutance G, Cauderlier E, Ehtisham J, et al., The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care 2011;15:R103. Go to original source... Go to PubMed...
  14. Kucher N, Rossi E, De Rosa M, Goldhaber SZ, Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Ann Intern Med 2005;165:1777-1781. Go to original source... Go to PubMed...
  15. Becattini C, Agnelli G, Vedovati MC, et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J 2011;32:1657-1663. Go to original source... Go to PubMed...
  16. Trujillo-Santos J, den Exter PL, Gómez V, et al. Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and metaanalysis. J Thromb Haemost 2013;11:1823-1832. Go to original source... Go to PubMed...
  17. Konstantinides S, Tiede N, Geibel A, et al. Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol 1998;82:966-970. Go to original source...
  18. Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012;125:465-470. Go to original source...
  19. Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141: e24S-e43S. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.